Tag: Mettler-Toledo InternationalSort
ENMD, CLNO, PWRM, MTD, PCP, CRM, - CRWESelect.com Stock News! EntreMed, Cleantech Transit, Power3 Medical Products
EntreMed, Inc. (NASDAQ:ENMD)
EntreMed, Inc. is a clinical-stage pharmaceutical company committed to developing ENMD-2076, a selective angiogenic kinase inhibitor, for the treatment of cancer.
ENMD-2076 is currently in a multi-center Phase 2 study in ovarian cancer and in several Phase 1 studies in solid tumors, multiple myeloma, and leukemia.